GlassScriptPhysician profile
Emily D Kriech
NPI 1891952750
$6,066.92
in general payments reported to CMS, 2019-2025
31 companies · $810 in 2025
The $810 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,527 · 2022: $2,044 · 2023: $740 · 2024: $945 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,103 · Travel and Lodging: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,102.88 |
| Travel and Lodging | $393.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,903.39 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Abbvie INC. | $684.16 | 2021-2025 | |
| Inspire Medical Systems, INC. | $324.11 | 2024-2025 | Inspire |
| Genzyme Corporation | $268.44 | 2021-2022 | |
| Harmony Biosciences LLC | $207.13 | 2023-2025 | Wakix |
| Ucb, INC. | $172.38 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $157.90 | 2021 | |
| Emd Serono, INC. | $142.99 | 2021-2024 | Mavenclad |
| Novartis Pharmaceuticals Corporation | $121.15 | 2021 | |
| Kyowa Kirin, INC. | $117.68 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $110.10 | 2023 | Lumryz |
| Horizon Therapeutics Plc | $95.25 | 2022 | |
| Genentech USA, INC. | $94.41 | 2022 | |
| Tg Therapeutics, INC. | $92.33 | 2023 | |
| Eisai INC. | $91.81 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $68.45 | 2021-2022 | |
| Amgen INC. | $56.15 | 2021-2025 | Uplizna |
| Sk Life Science, INC. | $52.80 | 2021 | |
| Neurelis, INC. | $43.89 | 2021 | |
| Allergan, INC. | $41.98 | 2022 | |
| Exact Sciences Corporation | $39.78 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $24.25 | 2025 | |
| Sanofi-Aventis U.S. LLC | $23.68 | 2021 | |
| Janssen Pharmaceuticals, INC | $22.15 | 2021 | |
| Lundbeck LLC | $18.87 | 2021 | |
| Greenwich Biosciences, INC. | $18.41 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $16.12 | 2021 | |
| Csl Behring | $15.57 | 2024 | Hizentra |
| E.R. Squibb & Sons, L.L.C. | $15.47 | 2021 | |
| Dexcom, INC. | $13.62 | 2023 | Dexcom G6 Transmitter |
| Avanir Pharmaceuticals, INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Kriech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.